Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

In Vivo Pharmacokinetics

At Sygnature Discovery we offer services to support your non-GLP in vivo Pharmacokinetics studies in preclinical species including the planning of these studies and the analysis of any samples generated by UPLC-MS.

Following storage of samples at either -20°C or -80°C, samples will be prepared and then analysed. A calibration curve with a minimum of 8 calibration standards and independent Quality Control (QC) samples are included. The analysis of dose formulation concentrations is included where required as part of our service.

All data generated will be shared in a summary spreadsheet which includes calculated PK parameters where required.

In vivo pharmacokinetic reports include all raw data, calculations and a summary table with calculated paraments and notes highlighting any suggestions or issues encountered. All typical PK parameters such as clearance, volume of distribution, AUC, half-life (T1/2), Cmax, Tmax and bioavailability are calculated using WinNonlin or equivalent software, following the industry standard for NCA and PK/PD Modeling and Simulation.

 

 

 

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.